Active ingredient
Bupropion
347 finished FDA listings contain Bupropion as their only active ingredient; 3 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- BUPROPION, BUPROPION HYDROBROMIDE, BUPROPION HYDROCHLORIDE
- Dosage forms
- Tablet, Tablet, Extended Release, Tablet, Film Coated, Tablet, Film Coated, Extended Release
- Routes
- Oral
- Manufacturers / labelers
- 79
- Strengths listed
- 100 mg/1 · 150 mg/1 · 174 mg/1 · 200 mg/1 · 300 mg/1 · 348 mg/1 · 450 mg/1 · 522 mg/1 · 75 mg/1
- Brand names in FDA listings
- Aplenzin, Bupropion, Bupropion Hcl Er (Xl), Bupropion Hydrochloride (Sr), Bupropion Hydrochloride (Xl), Bupropion Hydrochloride Sr, Bupropion Hydrochloride Xl, Forfivo Xl, Wellbutrin Sr, Wellbutrin Xl
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 42347
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 020358 | GLAXOSMITHKLINE | 1996-10-04 | 3 |
| ANDA 075584 | SENORES PHARMS | 2000-02-07 | 2 |
| ANDA 075491 | AUROBINDO PHARMA USA | 2000-04-17 | 7 |
| NDA 021515 | BAUSCH | 2003-08-28 | 2 |
| ANDA 075932 | EPIC PHARMA LLC | 2003-11-25 | 4 |
| ANDA 076143 | APOTEX | 2006-01-17 | 34 |
| ANDA 077415 | IMPAX LABS | 2006-12-15 | 2 |
| ANDA 077715 | ACTAVIS LABS FL INC | 2007-06-13 | 4 |
| NDA 022108 | BAUSCH | 2008-04-23 | 6 |
| ANDA 077285 | WATSON LABS INC | 2008-08-15 | 4 |
| ANDA 079094 | ACTAVIS LABS FL INC | 2009-03-24 | 2 |
| ANDA 079095 | ACTAVIS LABS FL INC | 2009-03-24 | 10 |
| ANDA 078866 | SUN PHARM | 2010-04-06 | 6 |
| ANDA 090325 | AUROBINDO PHARMA USA | 2010-04-08 | 3 |
| NDA 022497 | TWI PHARMS | 2011-11-10 | 3 |
| ANDA 201567 | ZYDUS PHARMS | 2014-01-17 | 5 |
| ANDA 202304 | PRINSTON INC | 2015-05-26 | 11 |
| ANDA 206674 | INVAGEN PHARMS | 2016-02-09 | 4 |
| ANDA 205794 | SCIEGEN PHARMS | 2016-03-01 | 33 |
| ANDA 206122 | SCIEGEN PHARMS | 2016-08-17 | 3 |
| ANDA 206975 | HERITAGE PHARMA | 2016-08-19 | 20 |
| ANDA 206556 | INVAGEN PHARMS | 2016-08-26 | 5 |
| ANDA 090693 | LUPIN | 2017-04-06 | 22 |
| ANDA 207479 | SCIEGEN PHARMS | 2017-04-12 | 25 |
| ANDA 207224 | ANBISON LAB | 2017-06-30 | 4 |
| ANDA 208652 | SINOTHERAPEUTICS INC | 2017-08-21 | 8 |
| ANDA 207389 | INVAGEN PHARMS | 2017-09-18 | 3 |
| ANDA 210081 | TWI PHARMS | 2017-11-03 | 5 |
| ANDA 203013 | ALEMBIC | 2018-06-08 | 6 |
| ANDA 210015 | YICHANG HUMANWELL | 2018-06-14 | 13 |
| ANDA 211347 | YICHANG HUMANWELL | 2018-10-16 | 10 |
| ANDA 210497 | ACCORD HLTHCARE | 2018-10-31 | 18 |
| ANDA 211020 | GRAVITI PHARMS | 2019-01-28 | 7 |
| ANDA 211200 | ZHEJIANG JUTAI PHARM | 2019-09-05 | 2 |
| ANDA 208606 | CADILA PHARMS LTD | 2020-01-16 | 4 |
| ANDA 215568 | GRANULES | 2022-02-02 | 16 |
| ANDA 216800 | ANNORA PHARMA | 2023-05-31 | 18 |
| ANDA 218385 | GRANULES | 2024-10-17 | 3 |
| ANDA 217898 | ANNORA PHARMA | 2025-10-01 | 2 |
| ANDA 218567 | MACLEODS PHARMS | 2026-06-23 | 3 |
Showing 40 of 44 applications.
Official labeling on DailyMed
- BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [QUALLENT PHARMACEUTICALS HEALTH LLC] · version 7 · 2026-09-10
- BUPROPION HYDROCHLORIDE TABLET, FILM COATED [APOTEX CORP] · version 23 · 2026-09-10
- BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] · version 4 · 2026-09-07
- BUPROPION HYDROCHLORIDE TABLET, FILM COATED [REMEDYREPACK INC.] · version 3 · 2026-09-03
- BUPROPION HCL ER(SR) TABLET, EXTENDED RELEASE [DRIECTRX] · version 2 · 2026-09-02
- BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] · version 4 · 2026-08-31
- BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [REMEDYREPACK INC.] · version 8 · 2026-08-31
- BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] · version 6 · 2026-08-31
- BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [GRANULES PHARMACEUTICALS INC.] · version 11 · 2026-08-31
- BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] · version 1 · 2026-08-31
- BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] · version 6 · 2026-08-28
- BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] · version 3 · 2026-08-27
Showing the 12 most recent of 246 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.